A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2011
11/10/2011	WO2011140160A1 Bicyclic heteroaryl compounds as gpr119 modulators
11/10/2011	WO2011140135A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
11/10/2011	WO2011140132A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
11/10/2011	WO2011139992A1 Aromatic-cationic peptides and uses of same
11/10/2011	WO2011139951A1 Modulators of fatty acid amide hydrolase
11/10/2011	WO2011139907A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
11/10/2011	WO2011139801A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
11/10/2011	WO2011139799A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
11/10/2011	WO2011139763A1 Methods and compositions for inducing satiety
11/10/2011	WO2011139714A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
11/10/2011	WO2011139391A1 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
11/10/2011	WO2011139379A2 A method of treating patients undergoing protein replacement therapy, gene replacement therapy, or other therapeutic modalities
11/10/2011	WO2011139107A2 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and phamaceutical composition comprising the same
11/10/2011	WO2011139010A1 Composition for the prevention or treatment of obesity, dyslipidaemia, fatty liver or insulin resistance syndrome, comprising piperonal as an active ingredient
11/10/2011	WO2011138977A1 Method of preventing or treating body weight-related disorders by employing vaspin
11/10/2011	WO2011138427A2 Pyridazinones as gpr119 agonists
11/10/2011	WO2011138421A1 Combination therapy
11/10/2011	WO2011138307A1 Pyrrolo [3, 2 -d] pyrimidin-3 -yl derivatives used as activators of ampk
11/10/2011	WO2011138266A1 Indolizine and imidazopyridine derivatives as orexin receptor antagonists
11/10/2011	WO2011137759A1 Novel ecdysterone synthesis derivative, preparation method and use thereof
11/10/2011	WO2011090265A3 Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome
11/10/2011	WO2011081493A3 Pharmaceutical composition comprising metformin and rosuvastatin
11/10/2011	WO2011072288A3 Insulin analogues with chlorinated amino acids
11/10/2011	US20110275716 Composition and method for treatment of diabetes
11/10/2011	US20110275706 Pharmaceutical Compositions Containing Lipase Inhibitors
11/10/2011	US20110275703 Substituted spiroketal derivatives and use thereof as therapeutic drug for diabetes
11/10/2011	US20110275699 Treatment For Obesity And Diabetes
11/10/2011	US20110275687 Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof
11/10/2011	US20110275684 Novel benzotriazole derivatives useful for the treatment of cns disorders
11/10/2011	US20110275681 Novel solid forms of epalrestat
11/10/2011	US20110275680 Noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
11/10/2011	US20110275679 Flupirtine hydrochloride maleic acid cocrystal
11/10/2011	US20110275678 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics
11/10/2011	US20110275673 Inhibitors of sphingosine kinase 1
11/10/2011	US20110275670 New Compounds VII
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275665 Glucokinase activators
11/10/2011	US20110275663 N-Acylthiourea and N-Acylurea Inhibitors of the Hedgehog Protein Signalling Pathway
11/10/2011	US20110275656 3H-Imidazo [4, 5-C] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
11/10/2011	US20110275650 Methods and compositions related to targeting monoacylglycerol lipase
11/10/2011	US20110275649 Combination therapy for the prevention of statin induced diabetes
11/10/2011	US20110275647 Pyrimidin-4-(3h)-one derivatives
11/10/2011	US20110275642 New method for obtaining 5-amino 2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine
11/10/2011	US20110275641 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275640 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275639 C5aR ANTAGONISTS
11/10/2011	US20110275638 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275637 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275636 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
11/10/2011	US20110275632 Method for preventing or treating a disease related to the glucocorticoid receptor
11/10/2011	US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011	US20110275623 Bi-functional pyrazolopyridine compounds
11/10/2011	US20110275622 Bi-functional quinoline analogs
11/10/2011	US20110275620 Method for preventing or treating a disease related to the glucocorticoid receptor
11/10/2011	US20110275611 Chemical compounds
11/10/2011	US20110275608 Piperidine-containing compounds and use thereof
11/10/2011	US20110275606 Substituted porphyrins
11/10/2011	US20110275605 Postprandial Hyperglycemia-Improving Agent
11/10/2011	US20110275600 Methods for increasing endogenous plasmalogen levels
11/10/2011	US20110275595 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
11/10/2011	US20110275579 Anti-diabetic extract of rooibos
11/10/2011	US20110275562 Inhibition of gliadin peptides
11/10/2011	US20110275561 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
11/10/2011	US20110275560 Synthetic conjugates and uses thereof
11/10/2011	US20110275559 Long-Acting Y2 and/or Y4 Receptor Agonists
11/10/2011	US20110275558 Lanthionine synthetase component c-like proteins as molecular targets for preventing and treating diseases and disorders
11/10/2011	US20110274758 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
11/10/2011	US20110274747 C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP-1)
11/10/2011	US20110274746 Therapeutic Liposomes and Methods For Producing and Using the Same
11/10/2011	US20110274719 Helicobacter system and uses thereof
11/10/2011	US20110274718 System for Modulating Expression of Hypothalmic Brain-Derived Neurotrophic Factor (BDNF)
11/10/2011	US20110274704 Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
11/10/2011	US20110274698 Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
11/10/2011	US20110274696 Antibodies to ccr2
11/10/2011	US20110274691 Ferroportin antibodies and methods of use
11/10/2011	US20110274689 Compounds and methods to measure metabolic function and restore normal metabolic function
11/10/2011	US20110274680 Chemical composition and its delivery for lowering the risks of alzheimer's, cardiov ascular and type-2 diabetes diseases
11/10/2011	US20110274667 Methods for obtaining cell populations from adipose tissue
11/10/2011	US20110274658 Chimeric activators: quantitatively designed protein therapeutics and uses thereof
11/10/2011	US20110274655 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011	US20110274653 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	US20110274650 Compositions and methods of treating inflammatory and autoimmune diseases
11/10/2011	US20110274638 Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics
11/10/2011	US20110274616 4-(2,6-dichloro-benzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
11/10/2011	CA2798082A1 Desazadesferrothiocin analogues as metal chelation agents
11/09/2011	EP2385032A1 GPR40 Receptor function regulator
11/09/2011	EP2384758A1 Polyacetylenic compounds
11/09/2011	EP2384750A1 Improved Glycemic Control for Prediabetes and/or Diabetes Type II using Docohexaenoic Acid
11/09/2011	EP2384328A1 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and process for preparing them
11/09/2011	EP1942898B1 Dipeptidyl peptidase inhibitors for treating diabetes
11/09/2011	EP1651620B1 Piperazine derivatives and their use as therapeutic agents
11/09/2011	EP1583529B1 Amino acid phenoxy ethers, their preparation and uses
11/09/2011	EP1461440B1 Cultured cells from pancreatic islets
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	EP1313769B2 Antibodies to human il-1 beta
11/09/2011	CN1931232B Oil-in-water nanometer perilla seed oil emulsion oral liquid and its preparation process
11/09/2011	CN1931219B Gynostemma pentaphylla micro emulsion medicine and its preparation
11/09/2011	CN1878760B Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s)-3, 5-dihydroxyhept-6-enoicacid] calcium salt
11/09/2011	CN1696300B Arachidonic acid and methods for the production and use thereof
11/09/2011	CN1248288B Nuclear transfer with differentiated fetal and adult donor cells

1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 1298